The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet

Bartlett, 2004, Mitochondrial Beta-oxidation, Eur. J. Biochem., 271, 462, 10.1046/j.1432-1033.2003.03947.x Beaton, 2012, Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Can. J. Gastroenterol., 26, 353, 10.1155/2012/725468 Bhathena, 2011, Diet-induced metabolic hamster model of nonalcoholic fatty liver disease, Diabetes Metab. Syndr. Obes., 4, 195 Braunersreuther, 2012, Role of cytokines and chemokines in non-alcoholic fatty liver disease, World J. Gastroenterol., 18, 727, 10.3748/wjg.v18.i8.727 Chan, 2013, Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress, Diabetes, 62, 2095, 10.2337/db12-1397 Chang, 2012, Beneficial impact of Zingiber zerumbet on insulin sensitivity in fructose-fed rats, Planta Med., 78, 317, 10.1055/s-0031-1298136 Chang, 2012, Regulation of lipid disorders by ethanol extracts from Zingiber zerumbet in high-fat diet-induced rats, Food Chem., 132, 460, 10.1016/j.foodchem.2011.11.022 Crozier, 2009, Dietary phenolics: chemistry, bioavailability and effects on health, Nat. Prod. Rep., 26, 1001, 10.1039/b802662a Dobrzyn, 2005, The role of stearoyl-CoA desaturase in the control of metabolism, Prostaglandins Leukot. Essent. Fatty Acids, 73, 35, 10.1016/j.plefa.2005.04.011 Folch, 1957, A simple method for the isolation and purification of total lipids from animal tissues, J. Biol. Chem., 226, 497, 10.1016/S0021-9258(18)64849-5 Hodge, 1967, Oral toxicity and metabolism of diuron (N-(3,4-dichlorophenyl)-N′, N′-dimethylurea) in rats and dogs, Food Cosmet. Toxicol., 5, 513, 10.1016/S0015-6264(67)83153-5 Huang, 2012, Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice, FASEB J., 26, 628, 10.1096/fj.11-194019 Ibrahim, 2010, Attenuation of cisplatin-induced nephrotoxicity in rats using zerumbone, Afr. J. Biotechnol., 9, 4434 Ibrahim, 2013, Nonalcoholic fatty liver disease: current and potential therapies, Life Sci., 92, 114, 10.1016/j.lfs.2012.11.004 Jensen-Urstad, 2012, Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?, Biochim. Biophys. Acta, 1821, 747, 10.1016/j.bbalip.2011.09.017 Kanda, 2006, MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, J. Clin. Invest., 116, 1494, 10.1172/JCI26498 Kraja, 2010, Fenofibrate and metabolic syndrome, Endocr. Metab. Immune Disord. Drug Targets, 10, 138, 10.2174/187153010791213047 Li, 2013, Adipokines and hepatic insulin resistance, J. Diabetes. Res., 2013, 170532, 10.1155/2013/170532 Lieber, 2004, Model of nonalcoholic steatohepatitis, Am. J. Clin. Nutr., 79, 502, 10.1093/ajcn/79.3.502 Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method, Methods, 25, 402, 10.1006/meth.2001.1262 Mao, 2006, Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis, Proc. Natl. Acad. Sci. USA, 103, 8552, 10.1073/pnas.0603115103 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Mormone, 2011, Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches, Chem. Biol. Interact., 193, 225, 10.1016/j.cbi.2011.07.001 Osborne, 2000, Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action, J. Biol. Chem., 275, 32379, 10.1074/jbc.R000017200 Paschos, 2009, Non alcoholic fatty liver disease and metabolic syndrome, Hippokratia, 13, 9 Poirier, 2006, Peroxisomal beta-oxidation-a metabolic pathway with multiple functions, Biochim. Biophys. Acta, 1763, 1413, 10.1016/j.bbamcr.2006.08.034 Rector, 2008, Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches, Adv. Drug Deliv. Rev., 60, 1488, 10.1016/j.addr.2008.04.014 Reddy, 2001, Peroxisomal beta-oxidation and peroxisome proliferator activated receptor alpha: an adaptive metabolic system, Annu. Rev. Nutr., 21, 193, 10.1146/annurev.nutr.21.1.193 Ruslay, 2007, Characterization of the components present in the active fractions of health gingers (Curcuma xanthorrhiza and Zingiber zerumbet) by HPLC-DAD-ESIMS, Food Chem., 104, 1183, 10.1016/j.foodchem.2007.01.067 Van Heek, 1997, Diet-induced obese mice develop peripheral, but not central, resistance to leptin, J. Clin. Invest., 99, 385, 10.1172/JCI119171 Yob, N.J., Jofrry, S.M., Affandi, M.M., Teh, L.K., Salleh, M.Z., Zakaria, Z.A., 2011. Zingiber zerumbet (L.) Smith: a review of its ethnomedicinal, chemical, and pharmacological uses. Evid. Complement. Alternat. Med., 543216.